Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKTX | AMGN | GILD | CELG | VRTX |
| Company | Akari Therapeutics ADR | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.2100 | 270.63 | 66.58 | 108.01 | 404.50 |
| High | 1.2100 | 274.86 | 67.18 | 108.59 | 406.83 |
| Low | 1.1701 | 269.64 | 66.36 | 107.27 | 399.29 |
| Last | 1.1900 | 273.01 | 67.08 | 108.24 | 400.76 |
| Change | -0.0200 | -0.53 | +0.05 | +0.11 | -4.15 |
| % Change | -1.65% | -0.19% | +0.07% | +0.10% | -1.02% |
| Volume | 7,500 | 2,467,100 | 8,467,000 | 191,230,496 | 806,400 |
| 20-Day Average Volume | 18,650 | 2,172,705 | 6,490,535 | 16,188,930 | 970,000 |
| Previous Close | 1.2100 | 273.54 | 67.03 | 108.13 | 404.91 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.3451 | 271.55 | 69.07 | 108.17 | 403.29 |
| 20-Day Raw Stochastic | 13.68% | 44.22% | 14.81% | 63.25% | 32.03% |
| 20-Day Relative Strength | 30.17% | 48.18% | 33.12% | 64.69% | 44.82% |
| Weighted Alpha | -70.49 | +11.15 | -20.78 | +46.30 | +16.09 |
| Today's Opinion | 100% Sell | 40% Sell | 100% Sell | 100% Buy | 8% Buy |
| Previous Opinion | 100% Sell | 40% Sell | 100% Sell | 100% Buy | 24% Buy |
| Last Month's Opinion | 100% Sell | 24% Buy | 88% Sell | 100% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.14% since 04/17/24 | +3.39% since 04/17/24 | +0.22% since 04/17/24 | -1.97% since 11/13/19 | +1.95% since 04/17/24 |
| Low | 1.0805 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 107.27 on 11/20/19 | 391.01 on 04/18/24 |
| High | 1.2350 on 04/23/24 | 274.86 on 04/24/24 | 67.68 on 04/23/24 | 110.53 on 11/14/19 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -34.25% since 03/22/24 | -1.14% since 03/22/24 | -7.62% since 03/22/24 | +5.14% since 10/18/19 | -3.58% since 03/22/24 |
| Low | 1.0775 on 04/17/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 1.8999 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -55.26% since 01/24/24 | -10.64% since 01/24/24 | -15.65% since 01/24/24 | +13.63% since 08/20/19 | -6.27% since 01/24/24 |
| Low | 1.0775 on 04/17/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 2.7400 on 02/02/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | -66.00% since 10/24/23 | -1.13% since 10/24/23 | -14.17% since 10/24/23 | +14.14% since 05/20/19 | +8.50% since 10/24/23 |
| Low | 1.0775 on 04/17/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 4.0700 on 10/25/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 9,588 | 146,720,288 | 83,457,512 | 77,035,920 | 104,652,640 |
| Shares Outstanding, K | 7,924 | 536,376 | 1,245,077 | 711,714 | 258,459 |
| Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -10,010,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -5,680,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | 0.96 | 0.58 | 0.19 | 1.41 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 09/27/22 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/06/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.58 | 9.96 | 10.99 | 29.76 |